Looking for a related edition? Inflammation Research (ISSN 1023-3830)

Inflammation Journal Citation Rate 2026

ISSN 0360-3997 eISSN 1573-2576 Springer Science+Business Media NL

Q1 Quartile Established Impact

About Inflammation
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Inflammation (I) is a peer-reviewed academic journal covering Asthma and respiratory diseases and Immune Response and Inflammation, published by Springer Science+Business Media in NL, catalogued under ISSN 0360-3997 (e-ISSN 1573-2576). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 4.16 (Q1 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It operates a subscription model (APC ~$4390 USD).

Inflammation Citation Rate 2026 — In Context

Inflammation has a 2025 2-Year Citation Rate (OpenAlex) of 4.16, placing it in the Q1 quartile within the Asthma and respiratory diseases research area. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

Inflammation operates a subscription-based publishing model — readers access articles through institutional subscriptions or pay-per-view.

Researchers looking to publish in Inflammation should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Inflammation against similar journals in the field, use our journal comparison tool.

Submission Tips for Inflammation
  • Budget $4390 for the Article Processing Charge. Check if your institution or funder covers OA fees.
  • This journal covers Asthma and respiratory diseases, Immune Response and Inflammation, Immune cells in cancer. Ensure your manuscript aligns with these scope areas to avoid desk rejection.
How Inflammation Compares
Citation Rate vs Field Avg
+7%
Field avg: 3.89
APC vs Field Avg
+27%
Field avg: $3444

Compared against 20 journals in the same research areas.

ISSN (Print) 0360-3997
ISSN (Online) 1573-2576
Publisher Springer Science+Business Media
Country Netherlands
APC / Cost $4390 USD
In-depth profile & metrics

Inflammation is published by Springer Science+Business Media and based in Netherlands. It runs on a subscription or hybrid model with an article-processing charge of USD 4390.

In our subject taxonomy, Inflammation is classified under Asthma and respiratory diseases, Immune Response and Inflammation, Immune cells in cancer and Inflammasome and immune disorders.

Inflammation is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 4.158.

Research Areas
Links
Frequently Asked Questions about Inflammation

Inflammation does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 4.158 — an open proxy for citation impact, not the licensed JCR Impact Factor.

No, Inflammation is not an open access journal.

The Article Processing Charge (APC) for Inflammation is $4390 USD.

Inflammation is published by Springer Science+Business Media.

Inflammation shows strong legitimacy signals: it is indexed in OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Inflammation is 0360-3997. Its electronic ISSN (eISSN) is 1573-2576.

Inflammation sits in the Q1 quartile based on its latest impact factor of 4.16, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Non-OA
Predatory Check
Clean
Citation Rate
4.158
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 4.158 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Research Highlights

Recently published high-impact papers in this journal:

Related Journals in Your Field

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S127393932

Get weekly updates for Asthma and respiratory diseases journals

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google